ABSI实时信号 | 通过Getagraph.com最大化利润

购买 136841 min ago

@ $4.70

发出时间: 15 Feb 2024 @ 03:13

回报率: -1.81%

上一信号: Feb 14 - 00:04

上一信号: 出售

回报率: 12.71 %

Live Chart Being Loaded With Signals

Commentary (18 May 2024 @ 04:00):

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States...

Stats
今日成交量	545 040
平均成交量	1.33M
市值	521.88M
EPS	$0 ( 2024-05-14 )
下一个收益日期	( $-0.190 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.85
ATR14	$0.00700 (0.15%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-19	Mcclain Sean	Buy	1 500 000	Common Stock
2024-03-01	Redmile Group, Llc	Buy	222 222	Common Stock
2023-12-31	Phoenix Venture Partners Ii Lp	Buy	0
2024-02-01	Bedrick Todd	Buy	20 570	Common Stock
2024-02-01	Bedrick Todd	Buy	86 790	Stock Option (right to buy)

INSIDER POWER
99.64
Last 93 transactions
Buy: 45 572 968 \| Sell: 7 130 968

音量相关性

長: 0.22 (neutral)

短: 0.98 (very strong)

Signal:(61.882) Expect same movement, but be aware

Absci Corporation 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Absci Corporation 相关性 - 货币/商品

0.42
( neutral )

0.33
( neutral )

0.00
( neutral )

-0.31
( neutral )

-0.35
( neutral )

Absci Corporation 财务报表

Annual	2023
营收:	$5.72M
毛利润:	$-8.28M (-144.82 %)
EPS:	$-1.200

FY	2023
营收:	$5.72M
毛利润:	$-8.28M (-144.82 %)
EPS:	$-1.200

FY	2022
营收:	$5.75M
毛利润:	$-7.29M (-126.85 %)
EPS:	$-1.150

FY	2021
营收:	$4.78M
毛利润:	$-1.87M (-39.15 %)
EPS:	$-1.117

Financial Reports:

No articles found.

Absci Corporation Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Absci Corporation

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

实时更新： Absci Corporation [ABSI]

Upcoming Earnings Alert

Absci Corporation Options Data

Calls

Puts